Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis
Crossref DOI link: https://doi.org/10.1007/s40264-015-0376-7
Published Online: 2016-01-09
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ledent, Edouard
Lieftucht, Alfons
Buyse, Hubert
Sugiyama, Keiji
Mckenna, Michael
Holl, Katsiaryna
Funding for this research was provided by:
GlaxoSmithKline Vaccines
Japan Vaccine Co., Ltd.
License valid from 2016-01-09